RecruitingNCT06876805
The Role of Ceus in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods
The Role of Contrast Enhanced Ultrasond (Ceus), in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
100 participants
Start Date
Aug 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The primary objective of the study is to determine the accuracy of CEUS in characterizing (as benign or malignant) focal liver lesions for which CT, MRI and/or PET have not been conclusive.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age ≥18 years.
- CEUS performed performed in the last 6 months a CT, MRI and/or PET not decisive in characterizing a liver lesion.
- Obtaining informed consent.
Exclusion Criteria2
- Technical impossibility to perform the ultrasound evaluation.
- Documented allergy to the ultrasound contrast medium.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTCEUS or Contrast enhanced Ultrasound
CEUS performed as normal clinical practice
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06876805